J.O.S.A.N.A...M.E.D.I.:.C.A.L...M.R.I.•.S.C.A.N...S.T.U.D.I.O.S
.J..O..S..A..N..A .M E D I : C A L.
M.R.I.+.M.R.A.,B.,C•S.C.A.N.+.SCREENING.PRO:JECT
3D–M.R.I+M.RA,B,C.•.SLICE-IMAGES:DIAGNOSTIC
------------------------------------------------------------------------
.JOSANA..MEDI:CAL..M R I •.S C A N..PRO:JECT.
.8–Minutes–P I T C H.
------------------------------------------------------------------------
.(
E n g l i s h
version*).
*K.I.–supported translation.
*K.I.–supported translation.
------------------------------------------------------------------------
.P a g e : A.1.a.
( Sequel / Continuation )
.P a g e : A.1.a.
( Sequel / Continuation )
of a
total of 8
pages
|....|....|....|
___________
.b–a–c–k..to.
Page 1
.> P I T C H <.
w w w . J O S A N A . o r g..–––>..P I T C H
.INTERNET.–.I.n.f.o.r.m.a.t.i.o.n.s.–.DOSSIER #.I.
JOSANA MEDI:CAL PRO:JECT –
.P I T C H.
(.Pitch = Short Summary.)
.Reading time :.8 minutes.
--> Part 2 <--
The present., non–public
INTERNET–Information–DOSSSIER
#.I.
"8 –.M i n u t e s –.P I T C H".
(.www.JOSANA.org.)
is directed at :
---------------------------------------------------------
A.} Potential..S T U D I O – F r a n c h i s e e s
B.} Potential..S T U D I O – I n v e s t o r s
C.} M R I • Large-Devices –.M a n u f a c t u r e r s
.D.} STRATEGY + BUSINESS – A d v i s o r s
JOSANA MEDI:CAL M R I •
S C A N PRO:JECT
Worldwide..M R.I.•
S.T.U.D.I.O –.C.h.a.i.n
S e q u e l /
C o n t i n u a t i o n
Part 2
Suitable JOSANA MEDI:CAL – '
M A J O R –
C O N S U L T A N T S '
would be
:
.--> Accenture <--.
--> Aon Hewitt <--
--> A.T..Kearney <--
--> Bain & Company <--
--> Boston Consulting Group <--
--> Capgemini Invent <--
--> Deloitte <--
--> Ernst &.Young <--
--> KPMG <--
--> McKinsey &.Company <--
--> Mercer <--
--> Oliver Wyman <--
--> PwC <--
--> Roland Berger <--
--> Willis.Towers.Watson <--
etc.
.--> Accenture <--.
--> Aon Hewitt <--
--> A.T..Kearney <--
--> Bain & Company <--
--> Boston Consulting Group <--
--> Capgemini Invent <--
--> Deloitte <--
--> Ernst &.Young <--
--> KPMG <--
--> McKinsey &.Company <--
--> Mercer <--
--> Oliver Wyman <--
--> PwC <--
--> Roland Berger <--
--> Willis.Towers.Watson <--
etc.
The prerequisite for the highly lucrative p.a.r.t.i.c.i.p.a.t.i.o.n of one
[1] o.r (.in the case of an '.A.l.l.i.a.n.c.e.'.) of several [1+] JOSANA
MEDI:CAL.–.'.M.A.J.O.R.–.C.O.N.S.U.L.T.A.N.T./.S.'..is the deployment
and the providing of highly qualified INTERIM–MANAGERS..for the
"JOSANA MEDI:CAL WORLD:GROUP".–.Company Parts ("Divisions")
to be established and to take over and carrying out the operational
coordination for the successful worldwide implementation of the
JOSANA MEDI:CAL M R I • S C A N PRO:JECT by filling the respec-
tive necessary Executive Functions and Managerial Positions with-
in the various JOSANA MEDI:CAL.–.Company Parts ("Divisions")
with qualified Chief Executive Officer(s) + Chief Financial Officer(s)
[1] o.r (.in the case of an '.A.l.l.i.a.n.c.e.'.) of several [1+] JOSANA
MEDI:CAL.–.'.M.A.J.O.R.–.C.O.N.S.U.L.T.A.N.T./.S.'..is the deployment
and the providing of highly qualified INTERIM–MANAGERS..for the
"JOSANA MEDI:CAL WORLD:GROUP".–.Company Parts ("Divisions")
to be established and to take over and carrying out the operational
coordination for the successful worldwide implementation of the
JOSANA MEDI:CAL M R I • S C A N PRO:JECT by filling the respec-
tive necessary Executive Functions and Managerial Positions with-
in the various JOSANA MEDI:CAL.–.Company Parts ("Divisions")
with qualified Chief Executive Officer(s) + Chief Financial Officer(s)
+ Chief HR Officer(s) + Chief Operation Officer(s) + Chief Information
Officer(s) + Chief Security Officer(s)
as well as the occupation with
Interim Directors of the JOSANA MEDI:CAL.–.companies areas of
Controlling.,
Finance.,
Purchasing.,
Logistics.,
Production.,
IT,
Marketing.,
Sales.,
Customer Service
and Human Resources.,
made up from carefully acquired Specialists.,
Executives and
Managers with top reputations from all over the world.
The JOSANA MEDI:CAL PRO:JECT – C o n c e p t o r s
The JOSANA MEDI:CAL PRO:JECT – Conceptors.,
in their function
as the leading Project–Developers and Majority–Shareholders of
the "JOSANA MEDI:CAL.WORLD:GROUP"
and of its subsidiary com-
panies.,
will take permanently advisory "Consultant"
tasks and will
assume functions as Board Members of the planned six [6]
n o n
–
p r o f i t..JOSANA MEDI:CAL MEDI:CAL.–
F.o.u.n.d.a.t.i.o.n.s..as well
as the Management of the already established JOSANA MEDI:CAL
PRO:JECT – Licensing–, Exploratory–, Preparatory–, Building-Up–,
Construction– and Platform.:.C.o.m.p.a.n.y
["JOSANA MEDICAL MRI
STUDIOS LICENSING LIMITED.".---> Sole Shareholder + Managing
..Director.:.Juergen.Zimmermann.,.Larnaca.,.Republic.of.Cyprus.,.E.U.].,
which will provide the."S.t.a.r.t.–.Funding".and the."S.t.a.r.t.–.Financ-
ing"
of the revolutionary JOSANA MEDI:CAL M R I = M R T • S C A N
. PRO:JECT.
The both JOSANA MEDI:CAL PRO:JECT – Conceptors +.Architects +
Initiators +.Licensors • Z I M M E R M A N N..&..R E H N I S C H..•
themselves will n o t perform any management–tasks or manage-
ment–functions within the future "JOSANA MEDI:CAL WORLD.:
GROUP.",
with the exception of functions in the "Supervisory
Board" [="Administrative Board"/"Management Presidium"/
"Verwaltungs–Präsidium"]
of the planned "JOSANA MEDI:CAL
WORLD.:.GROUP.".
The JOSANA MEDI:CAL PRO:JECT – Conceptors and JOSANA
MEDI:CAL M R I • S C A N –.Architects + Initiators +.Licensors
• Z I M M E R M A N N..&..R E H N I S C H..• at the moment (.until
MEDI:CAL M R I • S C A N –.Architects + Initiators +.Licensors
• Z I M M E R M A N N..&..R E H N I S C H..• at the moment (.until
revoked !.)..do..n..o..t..intend to assign any shares of their joint
M.a.j.o.r.i.t.y–Shareholdings in the future "JOSANA MEDI:CAL
M.a.j.o.r.i.t.y–Shareholdings in the future "JOSANA MEDI:CAL
WORLD:GROUP."
and in its Subsidiaries.
The prerequisite for a highly lucrative p.a.r.t.i.c.i.p.a.t.i.o.n of JOSANA
MEDI:CAL.–.(.BUILD-UP.).–.'.C.O.O.P.E.R.A.N.T.S.'
and..–.(.BUILD-UP.).–
'.P.A.R.T.I.C.I.P.A.N.T.S.'
of the different."T.R.A.D.E.S"
which are required
for the JOSANA MEDI:CAL M R I • S C A N PRO:JECT.,
and which also
applies to all the cooperation–interested.,
potential S T U D I O – I n -
v e s t o r s.,
M R I =.M R.T.•.Large.:.Devices.–.M.a.n.u.f.a.c.t.u.r.e.r.s
and
also to interested STRATEGY+MANAGEMENT+BUSINESS.–.A.d.v.i.s.o.r.s
who advise as "Business Consultants"
to the JOSANA MEDI:CAL PRO.:
JECT – Companies ("Divisions").,
will be.,
that they a l l are involved
into..the..revolutionary..JOSANA..MEDI:CAL M R I • S C A N..PRO:JECT
".f r o m..i t s..b e g i n n i n g.".
The future Headquarters Location and the future Companies Head
Offices Locations of the different parts ("Divisions")
of the planned
"JOSANA MEDI:CAL WORLD:GROUP."
will be determined in consider-
ation of the fiscal and of infrastructural and of local and political and
immobile and workforce–oriented and.,
last but n o t least.,
of subsidy–
related Location–Factors in joint coordination between the JOSANA
MEDI:CAL PRO:JECT – Conceptors and the future JOSANA MEDI:CAL –
'.M.A.J.O.R.–.C.O.N.S.U.L.T.A.N.T./.S.'
and in a timely manner [!]
"putting–into–practice".
.Notice
:
The JOSANA MEDI:CAL – Information–Languages are English.+.German..
The JOSANA MEDI:CAL – Contract–Language is German..
>.P I T C H.<
E n d
----------------------------------------------------------------------------------------
W H O – P r o g n o s i s.
----------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------
I N C R E A S E...I N...W O R L D W I D E...C A N C E R...C A S E S.
----------------------------------------------------------------------------------------
.
W H O – Prognosis
:
By 2050.,
there will be probably 77
percent.
more cases of cancer than in 2022 !
---------------------------------------------------.
The only effective remedy is :.
r e g u l a r P r e v e n t i v e – C a r e ! !
---------------------------------------------------.
According to a current forecast by the "International Agency.
for Research on Cancer".["IARC"].,
which is part of the "World
Health Organisation" ["WHO"].,
cancer will progress and there-
fore become more widespread.
.
Die."IARC".evaluated and analysed disease–data from a total
of 185
countries.
.
In 2022
alone.,
around 20
Million new cases of cancer occurred
worldwide
;
in 2020.,.according to an earlier."IARC"–.report.,
there were
19.3
Million new cancer–diagnoses worldwide per year in 2020.
.
According to estimates by the "International Agency for Re-
search on Cancer".of the."WHO",
the increase in annual cancer–
diagnoses will rise and increase to 35
Million new cancer–cases
worldwide per year by 2050.,
which corresponds to 77
percent
more new cancer–cases per year.
.
This means that one in five [5th]
people in the world will prob-
ably develop cancer in the course of his/her lifetime.
.
It is particularly dramatic that one
in nine [9]
men and one
in
twelve [12]
women are expected to die from it as a result.
.
According to the "International Agency for Research on Cancer"
["IARC"] of the "World Health Organisation" ["WHO"]., 9.7
Mil-
lion people worldwide died of cancer in 2022
alone.
.
Lung cancer,
breast cancer and bowel/colon cancer are the
most common types of cancer across all genders.
.
In women.,
breast cancer is the most common form.,
followed
by lung cancer and bowel/colon cancer.
In men.,
lung cancer is the most common form.,
followed by
prostate cancer and bowel/colon cancer.
.
In 2022.,
worldwide 2.5
Million people were diagnosed with
lung cancer.,
which corresponds to a total of 12.4
percent of
all cancer–cases detected.
.
In 2022.,.worldwide 2.3
Million women were diagnosed with
breast cancer.,
which corresponds to 11.6
percent of all can-
cer–cases.
In 2022.,
worldwide 1.9
Million people were diagnosed with
colorectal (.bowel/colon.) cancer.,
which corresponds to 9.6
percent of all cancer–cases.
This is followed in frequency by prostate cancer and stomach
This is followed in frequency by prostate cancer and stomach
cancer.
.
The reasons for the strong increase in cancer–cases and thus
cancer–diagnoses worldwide expected over the next few years
are.,
on the one hand.,
the increase in the population and --
on
the other hand --
the ever–increasing life expectancy of the
people.
.
Other important criteria for the expected massive increase in
cancer–cases are increased risks due to one's own lifestyle
with dangerous alcohol and tobacco consumption.,
but also
the problems of obesity across the population as well as the
problem of global air pollution..
The a n n u a l JOSANA MEDI:CAL M R I + MRA+MRB+
MRC..• W H O L E : B O D Y – S C R E E N I N G S ["S C A N S"]
include the examination of a l l the B o d y.–.S e g m e n t s
include the examination of a l l the B o d y.–.S e g m e n t s
listed..below :
.
Body–S e g m e n t #1 :
The HEAD
--- HEAD --- BRAIN --- NECK
--- SOFT THROAT
--- SALIVARY GLANDS
--- LARYNX
--- THYROID GLAND
Body–S e g m e n t #2 :
The SKELETON
--- ARMS
--- LEGS
--- BONES
--- SPINE
--- SPINAL CORD
Body–S e g m e n t #3 :
The MOVEMENT APPARATUS
--- LONG
--- CAPSULE STRUCTURES
--- TAPES
--- JOINTS
--- ARTICULATED DISCS
--- CARTILAGE
--- MUSCLE ATTACHMENTS
Body–S e g m e n t #4 :
The BODY–TISSUE
--- CONNECTIVE TISSUE
--- FAT TISSUE
--- MUSCLES
--- EPITHELIAL TISSUE
--- ANNOY
--- NERVE PATHWAYS
--- NERVE NODE
Body–S e g m e n t #5 :
The BLOOD + LYMPH + NERVE PATHWAYS
--- BLOOD VESSELS./.VEINS
--- CAPILLARY VESSELS
--- ARTERIES
--- VEINS
--- LEG VEINS
--- PELVIC VESSELS
--- LYMPH VESSELS./LYMPH PATHWAYS./LYMPH NODES
Body–S e g m e n t #6 :
The HEART* (*only limited examineable by MRI.)
--- HEART
--- HEART/CARDIAC VESSELS
--- CORONARY VESSELS
--- CARDIOVASCULAR SYSTEM
--- HEART VALVES
Body–S e g m e n t #7 :
The BREATHING
--- AIR TUBE
--- BREATHWAY/RESPIRATORY TRACT
--- LUNG* (.can be examined by MRB.)
--- BRONCHIA* (.can be examined by MRB.)
Body–S e g m e n t #8 :
The GLANDS
--- LIVER
--- BILE
--- PANCREAS
--- SPLEEN
Body–S e g m e n t #9 :
The DIGESTIVE
--- EGES TUBE/OESOPHAGUS
--- STOMACH (.MRI+MRC examinable.)
--- SMALL INTESTINE (.can be examined by MRC.)
--- LARGE INTESTINE/COLON (.can be examined by MRC.)
--- ENTIRE GUT/INDEX (.can be examined by MRC.)
Body–S e g m e n t #10 :
MAN + WOMAN
--- SEXUAL ORGANISM - female
--- SEXUAL ORGANISM - male
--- BREAST - female
--- PROSTATE - male
--- HORMONAL GLANDS - female/male
--- KIDNEYS./ADRENAL GLANDS
--- URINARY TRACT/URETER
--- BLADDER.
Body–S e g m e n t #1 :
The HEAD
--- HEAD --- BRAIN --- NECK
--- SOFT THROAT
--- SALIVARY GLANDS
--- LARYNX
--- THYROID GLAND
Body–S e g m e n t #2 :
The SKELETON
--- ARMS
--- LEGS
--- BONES
--- SPINE
--- SPINAL CORD
Body–S e g m e n t #3 :
The MOVEMENT APPARATUS
--- LONG
--- CAPSULE STRUCTURES
--- TAPES
--- JOINTS
--- ARTICULATED DISCS
--- CARTILAGE
--- MUSCLE ATTACHMENTS
Body–S e g m e n t #4 :
The BODY–TISSUE
--- CONNECTIVE TISSUE
--- FAT TISSUE
--- MUSCLES
--- EPITHELIAL TISSUE
--- ANNOY
--- NERVE PATHWAYS
--- NERVE NODE
Body–S e g m e n t #5 :
The BLOOD + LYMPH + NERVE PATHWAYS
--- BLOOD VESSELS./.VEINS
--- CAPILLARY VESSELS
--- ARTERIES
--- VEINS
--- LEG VEINS
--- PELVIC VESSELS
--- LYMPH VESSELS./LYMPH PATHWAYS./LYMPH NODES
Body–S e g m e n t #6 :
The HEART* (*only limited examineable by MRI.)
--- HEART
--- HEART/CARDIAC VESSELS
--- CORONARY VESSELS
--- CARDIOVASCULAR SYSTEM
--- HEART VALVES
Body–S e g m e n t #7 :
The BREATHING
--- AIR TUBE
--- BREATHWAY/RESPIRATORY TRACT
--- LUNG* (.can be examined by MRB.)
--- BRONCHIA* (.can be examined by MRB.)
Body–S e g m e n t #8 :
The GLANDS
--- LIVER
--- BILE
--- PANCREAS
--- SPLEEN
Body–S e g m e n t #9 :
The DIGESTIVE
--- EGES TUBE/OESOPHAGUS
--- STOMACH (.MRI+MRC examinable.)
--- SMALL INTESTINE (.can be examined by MRC.)
--- LARGE INTESTINE/COLON (.can be examined by MRC.)
--- ENTIRE GUT/INDEX (.can be examined by MRC.)
Body–S e g m e n t #10 :
MAN + WOMAN
--- SEXUAL ORGANISM - female
--- SEXUAL ORGANISM - male
--- BREAST - female
--- PROSTATE - male
--- HORMONAL GLANDS - female/male
--- KIDNEYS./ADRENAL GLANDS
--- URINARY TRACT/URETER
--- BLADDER.
--------------------------------------------------------------
--------------------------------------------------------------
I M P O R T A N T..N O T E
:
Further information about the JOSANA MEDI:CAL
Further information about the JOSANA MEDI:CAL
M R I • S C A N PRO:JECT is o n l y and e x c l u -
s i v e l y available in the exclusively w r i t t e n
INTERNET–Information–DOSSIER
#.I (.Part
1
+
Part
2.)
as well as in the DOSSIER
#.I.I
and espe-
cially in the final DOSSIER
#.I.I.I., which compre-
hensively explains..a l l..details.
.
N O FURTHER INFORMATION WILL BE PROVIDED
BY T E L E P H O N E OR IN ANY OTHER WAY
!
--------------------------------------------------------------.
--------------------------------------------------------------